The Medical Genome Initiative is a consortium working to expand access to high-quality genomic sequencing. A recent meta-analysis of 71 papers produced significant evidence that genomic sequencing excels as a Dx test for rare genetic diseases. bit.ly/3JGaAZv

Researchers at @JCSMR discovered a gene mutation that causes psoriasis – a chronic skin disease that causes red, scaly patches. How does this disease develop into psoriatic arthritis in some individuals and what will it mean for the future of care? bit.ly/43MMVzO

More labs and even nationwide health systems are adopting WGS for cancer. Learn why it can have an advantage over other methods, and what’s next for MRD testing. #AACR24 bit.ly/4anmNh4

Discover how PrimateAI-3D is revolutionizing variant interpretation and advancing precision medicine. Join Dr. Kyle Farh as he delves into the world of genomic AI on the latest @mendelspod episode: bit.ly/4an8XeT

We are proud to join @AmbryGenetics, @myriadgenetics, @QuestDX Oncology, @Volpara, @Alive_And_Kickn, and @FacingOurRisk to help increase evidence-based access to genetic testing for people with or at risk of hereditary cancers.